BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7843626)

  • 1. Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status.
    Lombardi G; Matera R; Minervini MM; Cascavilla N; D'Arcangelo P; Carotenuto M; Di Giorgio G; Musto P
    Haematologica; 1994; 79(5):406-12. PubMed ID: 7843626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
    Gharagozloo M; Karimi M; Amirghofran Z
    Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Treg cells and FoxP3 expression in immunity of β-thalassemia major AND β-thalassemia trait patients.
    Bozdogan G; Erdem E; Demirel GY; Yildirmak Y
    Pediatr Hematol Oncol; 2010 Oct; 27(7):534-45. PubMed ID: 20677925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
    Al-Awadhi AM; Alfadhli SM; Al-Khaldi D; Borhama M; Borusly M
    Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature senescence of T lymphocytes from patients with beta-thalassemia major.
    Gharagozloo M; Bagherpour B; Tahanian M; Oreizy F; Amirghofran Z; Sadeghi HM; Hourfar H; Moayedi B
    Immunol Lett; 2009 Jan; 122(1):84-8. PubMed ID: 19118576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
    Aggeli C; Antoniades C; Cosma C; Chrysohoou C; Tousoulis D; Ladis V; Karageorga M; Pitsavos C; Stefanadis C
    Int J Cardiol; 2005 Oct; 105(1):80-4. PubMed ID: 16207549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
    Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
    Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
    Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
    J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
    Al-Quobaili FA; Abou Asali IE
    Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-8 levels in thalassemia intermedia.
    Dore F; Bonfigli S; Pardini S; Longinotti M
    Haematologica; 1995; 80(5):431-3. PubMed ID: 8566884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
    Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
    Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune profile alterations in thalassaemic patients.
    Quintiliani L; Mastromonaco A; Giuliani E; Buzzonetti A; Sisti P; Guglielmetti M; Iudicone P; Greca E; Damiano AM; Ciancamerla AM
    Boll Ist Sieroter Milan; 1983; 62(6):524-30. PubMed ID: 6677264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy changes the pattern of cytokine production in beta-thalassemic patients.
    Moshtaghi-Kashanian GR; Gholamhoseinian A; Hoseinimoghadam A; Rajabalian S
    Cytokine; 2006 Sep; 35(5-6):253-7. PubMed ID: 17081768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
    J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.
    Daniel V; Trautmann Y; Konrad M; Nayir A; Schärer K
    Clin Nephrol; 1997 May; 47(5):289-97. PubMed ID: 9181275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune reactivity and cytokine status in polytrauma].
    Mkhoian GG; Ter-Pogosian ZR; Gasparian MG; Dzhagatspanian NG; Karalian ZA; Ovanesian GG
    Anesteziol Reanimatol; 2009; (4):60-5. PubMed ID: 19824419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.